Clinical Trials
36 trialsMulticenter Trial of ESK981 in Patients With Select Solid Tumors
University of Michigan Rogel Cancer Center
PRRT
Methodist Health System
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
Emory University
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
FARINET
IRCCS San Raffaele
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
University of Washington
NELMAS
Imperial College London
DENUTNE
University Hospital, Strasbourg, France
NET-PRO
University of Iowa
IMMUNORARE5
Hospices Civils de Lyon
OPERANDI-NET
Assistance Publique - Hôpitaux de Paris
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
Stanford University
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
National Health Research Institutes, Taiwan
NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
Case Comprehensive Cancer Center
NIP IT!
University Health Network, Toronto
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
Grupo Espanol de Tumores Neuroendocrinos
CABOTEM
National Cancer Institute, Naples
SAUNA
University Hospital, Antwerp
ETNA-FPG
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SPORE-3
University of Iowa
Beta plus
University Hospital, Basel, Switzerland
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
IRCCS San Raffaele
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
RGS-GEP-NET
European Institute of Oncology
PLANET
Duke University
REGOMUNE
Institut Bergonié
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
British Columbia Cancer Agency
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Memorial Sloan Kettering Cancer Center
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Pasireotide Treatment for Neuroendocrine Tumor
University of Maryland, Baltimore
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
H. Lee Moffitt Cancer Center and Research Institute
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
University of Wisconsin, Madison
LyREMeNet
Hospices Civils de Lyon
GaIN
Insel Gruppe AG, University Hospital Bern